XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 6,450 $ 4,452
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation 325 335
Amortization 3,335 3,242
Provision for (recovery of) losses on accounts receivable 8 (14)
Amortization of Right of Use Assets 21 19
Deferred income taxes 22 51
Stock-based compensation expense 82 72
Tax benefit attributable to exercise of stock options 5 7
Changes in operating assets and liabilities:    
Accounts receivable and other receivables (517) 903
Inventories 75 387
Prepaid expenses and other current assets (14) 40
Accounts payable 399 (528)
Accrued expenses 34 385
Total adjustments 3,775 4,899
Net cash provided by operating activities 10,225 9,351
CASH FLOWS FROM INVESTING ACTIVITIES:    
Property and equipment (222) (711)
Intangible assets 0 0
Net cash used in investing activities (222) (711)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock - options 92 79
Common stock purchased and retired 0 (6,426)
Payment of dividends (2,077) (2,077)
Net cash used in financing activities (1,985) (8,424)
Effect of exchange rate changes on cash (102) (651)
Net increase/(decrease) in cash and cash equivalents 7,916 (435)
Cash at beginning of period 51,590 42,787
Cash at end of period 59,506 42,352
Cash paid during the period for income taxes 2,279 786
Cash paid during the period for interest $ 0 $ 0